|
MXCT
|
MaxCyte, Inc.
|
US
|
NASDAQ
|
|
ORGS
|
Orgenesis Inc.
|
US
|
NASDAQ
|
|
PLUR
|
Pluri Inc.
|
US
|
NASDAQ
|
|
PROK
|
ProKidney Corp.
|
US
|
NASDAQ
|
|
SNTI
|
Senti Biosciences, Inc.
|
US
|
NASDAQ
|
|
SQZ
|
SQZ Biotechnologies Company
|
US
|
NYSE
|
|
TALS
|
Talaris Therapeutics, Inc.
|
US
|
NASDAQ
|
|
TCBP
|
TC BioPharm (Holdings) plc
|
US
|
NASDAQ
|
|
TCRT
|
Alaunos Therapeutics, Inc.
|
US
|
NASDAQ
|
|
TIL
|
Instil Bio, Inc.
|
US
|
NASDAQ
|
|
VCEL
|
Vericel Corporation
|
US
|
NASDAQ
|
|
CHM
|
Chimeric Therapeutics Limited NL
|
AU
|
ASX
|
|
AMBS
|
Amarantus Bioscience Holdings Inc
|
US
|
OTC
|
|
CLCS
|
Cell Source, Inc
|
US
|
OTC
|
|
CYYNF
|
Cynata Therapeutics Ltd Ordinar
|
US
|
OTC
|
|
GNNSF
|
Genscript Biotech Corp
|
US
|
OTC
|
|
HMTXF
|
Hemostemix Inc
|
US
|
OTC
|
|
JWCTF
|
Jw Cayman Therapeutics CO Ltd
|
US
|
OTC
|
|
LIFS
|
Life Stem Genetics Inc
|
US
|
OTC
|
|
LVCLF
|
Living Cell Technologies Ltd
|
US
|
OTC
|